HBV-host cfDNA as Minimal Residual Tumor Marker for HBV-related HCC
NCT03020342
·
clinicaltrials.gov ↗
UNKNOWN
Status
50
Enrollment
OTHER
Sponsor class
Conditions
Carcinoma, Hepatocellular
Sponsor
National Taiwan University Hospital